🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
BBR 2778 is a novel aza-anthracenedione that has activity in experimental t...
Status
Withdrawn
Location
Northwest Alabama Cancer Center
Start Date
2007-09
Trial ID
NCT00577161
Treatments Being Tested
The purpose of this study is to determine whether combining pixantrone (BBR...
Status
Terminated
Location
Arizona Clinical Research Center
Start Date
2005-01
Trial ID
NCT00060671
Treatments Being Tested
This is a phase I trial of the combination of bendamustine, rituximab and p...
Status
Completed
Location
Duke University Medical Center
Start Date
2011-11-01
Trial ID
NCT01491841
Treatments Being Tested
The aim of this trial is to determine the appropriate dose of pixantrone to...
Status
Completed
Location
Arizona Clinical Research Center
Start Date
2001-12
Trial ID
NCT00060684
Treatments Being Tested
This study will evaluate the efficacy of Pixantrone with rituximab, ifosfam...
Status
Completed
Location
AZ Sint Jan
Start Date
2018-12-26
Trial ID
NCT03458260
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as pixantrone, cytarabine, meth...
Status
Unknown
Location
Arizona Oncology Associates - Craycroft Road Offices
Start Date
2003-04
Trial ID
NCT00069966
This is a phase 1/2 open label study to assess the safety and efficacy of p...
Status
Unknown
Location
Department of Hematology, Aarhus University Hospital
Start Date
2016-02
Trial ID
NCT02678299
Treatments Being Tested
The purpose of this study is to compare the standard CHOP-R regimen of Cycl...
Status
Completed
Location
Bay Medical Oncology & Hematology
Start Date
2005-11
Trial ID
NCT00268853
BBR 2778 is a novel aza-anthracenedione that has activity in experimental t...
Status
Completed
Location
Robert A. Moss, M.D., FACP, Inc.
Start Date
2004-07
Trial ID
NCT00088530
RATIONALE: Drugs used in chemotherapy, such as fludarabine and pixantrone, ...
Status
Withdrawn
Location
Cell Therapeutics, Incorporated
Start Date
2007-08
Trial ID
NCT00551239
Treatments Being Tested